Replies to post #3751 on NorthWest Biotherapeutics Inc (NWBO)

[BioInfo]

I agree. Plus lot of folks complained about NWBO management, while I say I like them the way they are, consistent, tight lipped, could be the reason why FDA loves them.

When in doubt, always remember why FDA upgraded the phase 2 trials to phase 3 before interim analysis? That says it all the confidence FDA has in it. Why MD Anderson picked DCVax-D for trials at its famous centers? That says it all, they must have seen something tangible data that convinced them to do so.

All bashers, doubters, and haters, all banking on 90% success rate of Biotech failures, forgetting that the 10% that did succeed made millionares.

[austinmediainc]

I wouldn't put too much into this. Like Seeking Alpha, this is just a contributor and not actually a Motley Fool article.